"Uremic patients with hyperlipidemia are
classified at high atherogenic risk due to oxidative
stress induced by regular hemodialysis process
(hemoincompatibility) and a high level of oxidized
low-density lipoprotein (ox-LDL). This study aimed
to investigate whether LDL apheresis was capable of
reducing oxidative and atherogenic markers in uremic patients with hyperlipidemia. We found that
oxidative metabolites (methylquanidine, dityrosine,
and ox-LDL) and atherogenic markers (lipoprotein
(a), LDL, and LDL/HDL ratio) were significantly
reduced (P\0.05) after LDL apheresis. On the other
hand, plasma total antioxidant status (TAS) was no"
